| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Craniosynostoses | 17 | 2023 | 77 | 5.710 |
Why?
|
| Osteogenesis, Distraction | 11 | 2022 | 24 | 4.030 |
Why?
|
| Osteogenesis | 23 | 2020 | 242 | 3.260 |
Why?
|
| Mandible | 12 | 2022 | 119 | 3.200 |
Why?
|
| Pierre Robin Syndrome | 6 | 2022 | 13 | 3.180 |
Why?
|
| Skull | 13 | 2020 | 249 | 3.010 |
Why?
|
| Cranial Sutures | 9 | 2023 | 47 | 2.620 |
Why?
|
| Growth Differentiation Factor 2 | 18 | 2020 | 152 | 2.530 |
Why?
|
| Airway Obstruction | 6 | 2022 | 109 | 2.350 |
Why?
|
| Cell Differentiation | 22 | 2020 | 1458 | 1.670 |
Why?
|
| Osteoclasts | 5 | 2020 | 33 | 1.490 |
Why?
|
| Temporal Muscle | 2 | 2021 | 11 | 1.330 |
Why?
|
| Tissue Scaffolds | 6 | 2019 | 106 | 1.270 |
Why?
|
| Growth Differentiation Factors | 8 | 2019 | 57 | 1.230 |
Why?
|
| Proteome | 2 | 2018 | 124 | 1.120 |
Why?
|
| Surgical Flaps | 6 | 2015 | 241 | 1.110 |
Why?
|
| Osteoprotegerin | 3 | 2019 | 9 | 1.110 |
Why?
|
| Cleft Palate | 4 | 2022 | 25 | 1.070 |
Why?
|
| Infant | 19 | 2023 | 3046 | 1.070 |
Why?
|
| Printing, Three-Dimensional | 2 | 2023 | 37 | 1.050 |
Why?
|
| Osteotomy | 2 | 2023 | 31 | 0.990 |
Why?
|
| Orthognathic Surgical Procedures | 2 | 2021 | 18 | 0.980 |
Why?
|
| Bone Morphogenetic Proteins | 5 | 2012 | 126 | 0.940 |
Why?
|
| Wounds and Injuries | 3 | 2020 | 231 | 0.890 |
Why?
|
| Mastication | 1 | 2023 | 76 | 0.860 |
Why?
|
| Osteoblasts | 6 | 2020 | 95 | 0.820 |
Why?
|
| Orthognathic Surgery | 1 | 2021 | 9 | 0.800 |
Why?
|
| Micrognathism | 3 | 2017 | 11 | 0.800 |
Why?
|
| X-Ray Microtomography | 3 | 2019 | 80 | 0.780 |
Why?
|
| Humans | 84 | 2023 | 86643 | 0.780 |
Why?
|
| Nanocomposites | 1 | 2019 | 11 | 0.720 |
Why?
|
| Trauma Centers | 1 | 2020 | 116 | 0.710 |
Why?
|
| Facial Bones | 4 | 2022 | 37 | 0.710 |
Why?
|
| Adipocytes | 3 | 2019 | 155 | 0.700 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2019 | 78 | 0.690 |
Why?
|
| Signal Transduction | 10 | 2023 | 3241 | 0.690 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2020 | 2601 | 0.690 |
Why?
|
| Craniofacial Abnormalities | 6 | 2020 | 36 | 0.670 |
Why?
|
| Proteomics | 2 | 2018 | 212 | 0.650 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 316 | 0.650 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 301 | 0.640 |
Why?
|
| Betacoronavirus | 2 | 2020 | 258 | 0.640 |
Why?
|
| Wound Healing | 5 | 2006 | 344 | 0.610 |
Why?
|
| Transduction, Genetic | 2 | 2017 | 153 | 0.610 |
Why?
|
| Osseointegration | 1 | 2017 | 11 | 0.600 |
Why?
|
| Fracture Healing | 1 | 2017 | 34 | 0.590 |
Why?
|
| Pandemics | 4 | 2021 | 740 | 0.580 |
Why?
|
| Cicatrix, Hypertrophic | 2 | 2006 | 8 | 0.570 |
Why?
|
| Retrospective Studies | 16 | 2022 | 8489 | 0.550 |
Why?
|
| Mice | 21 | 2019 | 11352 | 0.550 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2020 | 579 | 0.540 |
Why?
|
| Preoperative Care | 1 | 2018 | 397 | 0.540 |
Why?
|
| Rhytidoplasty | 1 | 2015 | 11 | 0.530 |
Why?
|
| Facial Paralysis | 1 | 2015 | 17 | 0.530 |
Why?
|
| Fascia | 1 | 2015 | 30 | 0.530 |
Why?
|
| Biocompatible Materials | 7 | 2019 | 193 | 0.530 |
Why?
|
| Animals | 29 | 2023 | 26582 | 0.520 |
Why?
|
| Surgery, Plastic | 4 | 2021 | 42 | 0.520 |
Why?
|
| Child, Preschool | 11 | 2020 | 3612 | 0.500 |
Why?
|
| Cell Line | 12 | 2019 | 2468 | 0.490 |
Why?
|
| Protective Devices | 2 | 2013 | 8 | 0.490 |
Why?
|
| Oral Surgical Procedures | 3 | 2010 | 19 | 0.470 |
Why?
|
| Skin | 4 | 2009 | 554 | 0.470 |
Why?
|
| External Fixators | 1 | 2013 | 19 | 0.460 |
Why?
|
| Electromagnetic Fields | 1 | 2012 | 26 | 0.420 |
Why?
|
| Tissue Engineering | 4 | 2019 | 181 | 0.420 |
Why?
|
| Stem Cell Transplantation | 2 | 2012 | 183 | 0.420 |
Why?
|
| Face | 1 | 2012 | 114 | 0.420 |
Why?
|
| Ear, External | 2 | 2010 | 26 | 0.410 |
Why?
|
| Male | 36 | 2020 | 40965 | 0.410 |
Why?
|
| RANK Ligand | 1 | 2011 | 8 | 0.400 |
Why?
|
| Adipogenesis | 3 | 2018 | 38 | 0.400 |
Why?
|
| Treatment Outcome | 12 | 2022 | 7993 | 0.400 |
Why?
|
| Bone Transplantation | 4 | 2015 | 64 | 0.380 |
Why?
|
| Genetic Vectors | 5 | 2018 | 439 | 0.370 |
Why?
|
| Surgery Department, Hospital | 2 | 2020 | 42 | 0.360 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2020 | 273 | 0.350 |
Why?
|
| Infant, Newborn | 8 | 2020 | 2379 | 0.350 |
Why?
|
| HEK293 Cells | 7 | 2020 | 615 | 0.350 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2009 | 5 | 0.350 |
Why?
|
| Mandibular Fractures | 1 | 2009 | 7 | 0.350 |
Why?
|
| Female | 32 | 2020 | 44532 | 0.340 |
Why?
|
| Absorbable Implants | 1 | 2009 | 34 | 0.340 |
Why?
|
| Arteriovenous Malformations | 2 | 2010 | 41 | 0.340 |
Why?
|
| Homeostasis | 1 | 2011 | 409 | 0.330 |
Why?
|
| Tongue | 3 | 2022 | 57 | 0.330 |
Why?
|
| Precision Medicine | 1 | 2012 | 395 | 0.330 |
Why?
|
| Child | 13 | 2020 | 6927 | 0.320 |
Why?
|
| Surgical Wound Infection | 4 | 2015 | 184 | 0.320 |
Why?
|
| Postoperative Complications | 7 | 2018 | 2207 | 0.320 |
Why?
|
| Calcium-Binding Proteins | 2 | 2020 | 115 | 0.320 |
Why?
|
| Adenoviridae | 4 | 2017 | 345 | 0.310 |
Why?
|
| Adolescent | 11 | 2020 | 8981 | 0.310 |
Why?
|
| Maxillofacial Development | 1 | 2007 | 4 | 0.310 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 1169 | 0.300 |
Why?
|
| Genetic Therapy | 2 | 2006 | 342 | 0.300 |
Why?
|
| Models, Anatomic | 3 | 2023 | 91 | 0.300 |
Why?
|
| Frontal Bone | 3 | 2018 | 16 | 0.300 |
Why?
|
| Recurrence | 4 | 2022 | 1139 | 0.290 |
Why?
|
| Endoscopy | 2 | 2021 | 332 | 0.280 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2006 | 40 | 0.280 |
Why?
|
| Ischemia | 2 | 2006 | 243 | 0.280 |
Why?
|
| Bone and Bones | 6 | 2019 | 265 | 0.280 |
Why?
|
| Eyelids | 1 | 2006 | 23 | 0.280 |
Why?
|
| Metalloendopeptidases | 1 | 2006 | 45 | 0.280 |
Why?
|
| Oculomotor Muscles | 1 | 2006 | 28 | 0.280 |
Why?
|
| Cells, Cultured | 6 | 2019 | 2818 | 0.270 |
Why?
|
| Lipectomy | 1 | 2005 | 9 | 0.270 |
Why?
|
| Stem Cells | 4 | 2019 | 351 | 0.270 |
Why?
|
| Hernia, Umbilical | 1 | 2005 | 17 | 0.270 |
Why?
|
| Registries | 3 | 2018 | 702 | 0.270 |
Why?
|
| Abdominal Wall | 1 | 2005 | 30 | 0.260 |
Why?
|
| Adipose Tissue | 2 | 2018 | 240 | 0.260 |
Why?
|
| Temporomandibular Joint Disorders | 2 | 2020 | 19 | 0.260 |
Why?
|
| Ulnar Artery | 1 | 2004 | 5 | 0.260 |
Why?
|
| Sensitivity and Specificity | 3 | 2019 | 1991 | 0.250 |
Why?
|
| Sutures | 2 | 2023 | 52 | 0.240 |
Why?
|
| Disease Models, Animal | 4 | 2006 | 2232 | 0.240 |
Why?
|
| Biomechanical Phenomena | 2 | 2023 | 457 | 0.240 |
Why?
|
| Case-Control Studies | 2 | 2020 | 1805 | 0.240 |
Why?
|
| Maxilla | 2 | 2018 | 19 | 0.240 |
Why?
|
| Esophageal Fistula | 1 | 2004 | 10 | 0.240 |
Why?
|
| Transforming Growth Factor beta | 1 | 2006 | 301 | 0.240 |
Why?
|
| Suction | 1 | 2003 | 35 | 0.240 |
Why?
|
| beta Catenin | 4 | 2022 | 251 | 0.240 |
Why?
|
| Free Tissue Flaps | 2 | 2015 | 49 | 0.230 |
Why?
|
| Internship and Residency | 3 | 2021 | 1004 | 0.230 |
Why?
|
| Up-Regulation | 4 | 2018 | 712 | 0.230 |
Why?
|
| Primary Cell Culture | 2 | 2020 | 72 | 0.230 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 1753 | 0.230 |
Why?
|
| Spinal Fusion | 1 | 2004 | 85 | 0.220 |
Why?
|
| Gelatin | 3 | 2017 | 25 | 0.220 |
Why?
|
| Pyrvinium Compounds | 1 | 2022 | 5 | 0.220 |
Why?
|
| Calcification, Physiologic | 3 | 2019 | 33 | 0.220 |
Why?
|
| Reperfusion Injury | 1 | 2004 | 131 | 0.220 |
Why?
|
| Muscle, Skeletal | 2 | 2009 | 449 | 0.220 |
Why?
|
| Practice Patterns, Dentists' | 1 | 2021 | 3 | 0.200 |
Why?
|
| Trismus | 1 | 2021 | 6 | 0.200 |
Why?
|
| Cephalometry | 3 | 2017 | 50 | 0.200 |
Why?
|
| Neovascularization, Physiologic | 2 | 2017 | 133 | 0.200 |
Why?
|
| Ulna | 1 | 2021 | 13 | 0.200 |
Why?
|
| Adult | 11 | 2021 | 25648 | 0.200 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2016 | 219 | 0.200 |
Why?
|
| Prescriptions | 1 | 2021 | 21 | 0.200 |
Why?
|
| Immunoenzyme Techniques | 2 | 2012 | 303 | 0.200 |
Why?
|
| Clinical Protocols | 2 | 2020 | 156 | 0.200 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 1920 | 0.200 |
Why?
|
| Gene Transfer Techniques | 2 | 2015 | 152 | 0.190 |
Why?
|
| Universities | 1 | 2021 | 135 | 0.190 |
Why?
|
| Abnormalities, Multiple | 2 | 2020 | 232 | 0.190 |
Why?
|
| Chondrogenesis | 2 | 2018 | 26 | 0.180 |
Why?
|
| Polysomnography | 2 | 2017 | 151 | 0.180 |
Why?
|
| Language Development Disorders | 1 | 2020 | 24 | 0.180 |
Why?
|
| Emergencies | 1 | 2020 | 113 | 0.180 |
Why?
|
| Anemia | 1 | 2020 | 128 | 0.180 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 46 | 0.180 |
Why?
|
| Models, Animal | 2 | 2015 | 263 | 0.180 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 4 | 2013 | 23 | 0.180 |
Why?
|
| Cleft Lip | 1 | 2019 | 15 | 0.180 |
Why?
|
| Databases, Factual | 1 | 2023 | 814 | 0.180 |
Why?
|
| Bone Resorption | 1 | 2019 | 41 | 0.170 |
Why?
|
| Reoperation | 3 | 2017 | 597 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 879 | 0.170 |
Why?
|
| Wnt Proteins | 2 | 2011 | 123 | 0.170 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 116 | 0.170 |
Why?
|
| Bioprinting | 1 | 2019 | 13 | 0.170 |
Why?
|
| Operating Rooms | 1 | 2020 | 126 | 0.170 |
Why?
|
| Infection Control | 1 | 2020 | 115 | 0.170 |
Why?
|
| RNA, Messenger | 2 | 2018 | 1981 | 0.170 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 240 | 0.170 |
Why?
|
| Fibroblasts | 4 | 2020 | 729 | 0.170 |
Why?
|
| Obesity | 1 | 2005 | 963 | 0.170 |
Why?
|
| Umbilical Cord | 1 | 2018 | 40 | 0.160 |
Why?
|
| Health Policy | 1 | 2020 | 180 | 0.160 |
Why?
|
| Nanoparticles | 2 | 2019 | 157 | 0.160 |
Why?
|
| Intellectual Disability | 1 | 2020 | 186 | 0.160 |
Why?
|
| Hydrogels | 1 | 2019 | 82 | 0.160 |
Why?
|
| Strontium | 1 | 2018 | 6 | 0.160 |
Why?
|
| Collagen Type VI | 1 | 2018 | 5 | 0.160 |
Why?
|
| Cerebellum | 2 | 2020 | 247 | 0.160 |
Why?
|
| Equipment Design | 2 | 2013 | 406 | 0.160 |
Why?
|
| Chicago | 2 | 2020 | 1379 | 0.160 |
Why?
|
| Receptors, Notch | 1 | 2018 | 120 | 0.160 |
Why?
|
| In Vitro Techniques | 1 | 2019 | 989 | 0.160 |
Why?
|
| Peptides, Cyclic | 1 | 2018 | 43 | 0.160 |
Why?
|
| Citric Acid | 1 | 2018 | 38 | 0.160 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 279 | 0.160 |
Why?
|
| Polyethylene Glycols | 2 | 2017 | 363 | 0.150 |
Why?
|
| Mice, Knockout | 3 | 2015 | 1924 | 0.150 |
Why?
|
| Propensity Score | 1 | 2018 | 136 | 0.150 |
Why?
|
| Genomics | 1 | 2023 | 720 | 0.150 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 103 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 123 | 0.150 |
Why?
|
| Proteoglycans | 1 | 2018 | 121 | 0.150 |
Why?
|
| Biotechnology | 1 | 2017 | 28 | 0.150 |
Why?
|
| Phosphates | 1 | 2018 | 160 | 0.150 |
Why?
|
| Bone Regeneration | 4 | 2019 | 52 | 0.150 |
Why?
|
| Alkaline Phosphatase | 3 | 2012 | 132 | 0.150 |
Why?
|
| Trans-Activators | 1 | 2020 | 429 | 0.150 |
Why?
|
| Bone Matrix | 2 | 2014 | 18 | 0.150 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 2018 | 47 | 0.150 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 315 | 0.150 |
Why?
|
| Founder Effect | 1 | 2017 | 104 | 0.150 |
Why?
|
| Receptor, Notch1 | 1 | 2017 | 85 | 0.150 |
Why?
|
| Durapatite | 1 | 2016 | 28 | 0.150 |
Why?
|
| Genetic Engineering | 1 | 2017 | 114 | 0.140 |
Why?
|
| Rabbits | 3 | 2006 | 636 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 413 | 0.140 |
Why?
|
| Follow-Up Studies | 6 | 2013 | 3640 | 0.140 |
Why?
|
| Blepharoplasty | 2 | 2006 | 8 | 0.140 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 547 | 0.140 |
Why?
|
| Aged | 7 | 2020 | 18415 | 0.140 |
Why?
|
| Ear | 2 | 2006 | 18 | 0.140 |
Why?
|
| Occipital Bone | 1 | 2016 | 18 | 0.140 |
Why?
|
| Prostheses and Implants | 2 | 2009 | 121 | 0.140 |
Why?
|
| Patient Selection | 1 | 2020 | 685 | 0.140 |
Why?
|
| Mice, Nude | 5 | 2018 | 790 | 0.140 |
Why?
|
| Encephalocele | 1 | 2016 | 24 | 0.140 |
Why?
|
| Cell Proliferation | 6 | 2019 | 1578 | 0.140 |
Why?
|
| Neurosurgical Procedures | 1 | 2018 | 213 | 0.140 |
Why?
|
| Cell Culture Techniques | 2 | 2018 | 188 | 0.140 |
Why?
|
| Smiling | 1 | 2015 | 2 | 0.130 |
Why?
|
| Glycoproteins | 1 | 2017 | 234 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 582 | 0.130 |
Why?
|
| Patient Care Planning | 1 | 2016 | 81 | 0.130 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 369 | 0.130 |
Why?
|
| Perioperative Care | 1 | 2017 | 161 | 0.130 |
Why?
|
| Facial Expression | 1 | 2015 | 51 | 0.130 |
Why?
|
| Young Adult | 4 | 2020 | 5976 | 0.130 |
Why?
|
| Osteocalcin | 2 | 2012 | 26 | 0.130 |
Why?
|
| Random Allocation | 1 | 2015 | 332 | 0.130 |
Why?
|
| Collagen | 1 | 2016 | 269 | 0.130 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2015 | 78 | 0.130 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2016 | 99 | 0.130 |
Why?
|
| Osteopontin | 2 | 2012 | 47 | 0.130 |
Why?
|
| User-Computer Interface | 1 | 2016 | 185 | 0.120 |
Why?
|
| Decision Making | 1 | 2020 | 642 | 0.120 |
Why?
|
| Middle Aged | 8 | 2020 | 25028 | 0.120 |
Why?
|
| Skull Fractures | 1 | 2014 | 24 | 0.120 |
Why?
|
| Parietal Bone | 1 | 2014 | 20 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 3092 | 0.120 |
Why?
|
| Animals, Newborn | 1 | 2015 | 510 | 0.120 |
Why?
|
| Consumer Behavior | 1 | 2013 | 29 | 0.120 |
Why?
|
| Neural Tube Defects | 1 | 2014 | 43 | 0.120 |
Why?
|
| Blood Transfusion | 3 | 2020 | 157 | 0.120 |
Why?
|
| Clinical Competence | 1 | 2019 | 751 | 0.120 |
Why?
|
| Professional-Family Relations | 1 | 2013 | 48 | 0.120 |
Why?
|
| Respiratory Aspiration | 1 | 2013 | 5 | 0.120 |
Why?
|
| Craniotomy | 1 | 2014 | 88 | 0.120 |
Why?
|
| Temporal Bone | 1 | 2014 | 66 | 0.120 |
Why?
|
| Maxillofacial Injuries | 1 | 2012 | 4 | 0.110 |
Why?
|
| Arm | 1 | 2013 | 91 | 0.110 |
Why?
|
| Gene Expression | 3 | 2019 | 1284 | 0.110 |
Why?
|
| Equipment Failure | 1 | 2013 | 119 | 0.110 |
Why?
|
| Cerebral Palsy | 1 | 2013 | 90 | 0.110 |
Why?
|
| Head Protective Devices | 1 | 2012 | 20 | 0.110 |
Why?
|
| Cell Adhesion | 3 | 2019 | 420 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 68 | 0.110 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 125 | 0.100 |
Why?
|
| Arteries | 2 | 2013 | 176 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6509 | 0.100 |
Why?
|
| Plagiocephaly, Nonsynostotic | 1 | 2011 | 3 | 0.100 |
Why?
|
| Fractures, Bone | 1 | 2012 | 131 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 222 | 0.100 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2010 | 33 | 0.100 |
Why?
|
| Parents | 1 | 2013 | 272 | 0.100 |
Why?
|
| Referral and Consultation | 1 | 2013 | 328 | 0.100 |
Why?
|
| Bone Diseases | 1 | 2011 | 54 | 0.100 |
Why?
|
| Skull Base | 1 | 2011 | 47 | 0.090 |
Why?
|
| Hydroxyapatites | 1 | 2010 | 7 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2018 | 912 | 0.090 |
Why?
|
| Molar | 1 | 2010 | 21 | 0.090 |
Why?
|
| Hemostasis, Surgical | 1 | 2010 | 26 | 0.090 |
Why?
|
| Bandages | 1 | 2010 | 41 | 0.090 |
Why?
|
| Radiographic Image Enhancement | 1 | 2012 | 462 | 0.090 |
Why?
|
| Masks | 1 | 2010 | 29 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 2 | 2012 | 305 | 0.090 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 31 | 0.090 |
Why?
|
| Scalp | 1 | 2009 | 72 | 0.090 |
Why?
|
| Polyesters | 1 | 2009 | 41 | 0.090 |
Why?
|
| Lactic Acid | 1 | 2009 | 90 | 0.080 |
Why?
|
| DNA | 1 | 2014 | 1294 | 0.080 |
Why?
|
| Surgical Mesh | 1 | 2009 | 116 | 0.080 |
Why?
|
| Ear Neoplasms | 1 | 2008 | 10 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2009 | 270 | 0.080 |
Why?
|
| Bone Development | 1 | 2008 | 34 | 0.080 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2008 | 54 | 0.080 |
Why?
|
| Extraoral Traction Appliances | 1 | 2007 | 2 | 0.080 |
Why?
|
| Retrognathia | 1 | 2007 | 3 | 0.080 |
Why?
|
| United States | 1 | 2020 | 6672 | 0.080 |
Why?
|
| Synostosis | 1 | 2007 | 1 | 0.080 |
Why?
|
| Regional Blood Flow | 1 | 2008 | 197 | 0.080 |
Why?
|
| Polymers | 1 | 2009 | 202 | 0.080 |
Why?
|
| Skin Ulcer | 2 | 2006 | 25 | 0.080 |
Why?
|
| Osteosarcoma | 1 | 2008 | 158 | 0.080 |
Why?
|
| Neoplasms | 1 | 2022 | 2898 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 165 | 0.080 |
Why?
|
| Cell Division | 1 | 2008 | 696 | 0.070 |
Why?
|
| Time Factors | 2 | 2007 | 5210 | 0.070 |
Why?
|
| Ankylosis | 1 | 2006 | 4 | 0.070 |
Why?
|
| Injections, Intradermal | 1 | 2006 | 19 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 1 | 1 | 2006 | 2 | 0.070 |
Why?
|
| Blepharoptosis | 1 | 2006 | 11 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 1052 | 0.070 |
Why?
|
| Telomerase | 1 | 2006 | 55 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 388 | 0.070 |
Why?
|
| Retroviridae | 1 | 2006 | 79 | 0.070 |
Why?
|
| Temperature | 2 | 2018 | 396 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2018 | 4213 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 268 | 0.070 |
Why?
|
| Attitude to Health | 1 | 2006 | 220 | 0.060 |
Why?
|
| Granulation Tissue | 1 | 2004 | 15 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 865 | 0.060 |
Why?
|
| RNA Interference | 2 | 2017 | 369 | 0.060 |
Why?
|
| Silicones | 2 | 2019 | 16 | 0.060 |
Why?
|
| Tensile Strength | 1 | 2004 | 79 | 0.060 |
Why?
|
| Cell Lineage | 3 | 2012 | 273 | 0.060 |
Why?
|
| Syndrome | 2 | 2020 | 446 | 0.060 |
Why?
|
| Transfection | 1 | 2006 | 896 | 0.060 |
Why?
|
| Esophageal Perforation | 1 | 2004 | 18 | 0.060 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 63 | 0.060 |
Why?
|
| Magnetics | 1 | 2004 | 41 | 0.060 |
Why?
|
| Sampling Studies | 1 | 2003 | 70 | 0.060 |
Why?
|
| Biomarkers | 2 | 2010 | 1718 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2004 | 86 | 0.060 |
Why?
|
| Computer Systems | 1 | 2004 | 79 | 0.060 |
Why?
|
| Iatrogenic Disease | 1 | 2004 | 69 | 0.060 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2017 | 53 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 623 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 125 | 0.060 |
Why?
|
| Microsurgery | 1 | 2004 | 84 | 0.060 |
Why?
|
| Periodicity | 1 | 2004 | 119 | 0.060 |
Why?
|
| Length of Stay | 2 | 2017 | 702 | 0.050 |
Why?
|
| Obesity, Morbid | 1 | 2005 | 225 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2003 | 221 | 0.050 |
Why?
|
| Radiography | 1 | 2004 | 813 | 0.050 |
Why?
|
| Mutation | 2 | 2020 | 3968 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2005 | 770 | 0.050 |
Why?
|
| Wnt Signaling Pathway | 1 | 2022 | 91 | 0.050 |
Why?
|
| Comorbidity | 1 | 2005 | 943 | 0.050 |
Why?
|
| Philadelphia | 2 | 2013 | 16 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 927 | 0.050 |
Why?
|
| Algorithms | 1 | 2009 | 1830 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 1540 | 0.050 |
Why?
|
| Joint Prosthesis | 1 | 2020 | 26 | 0.050 |
Why?
|
| Hospitals, Pediatric | 2 | 2013 | 106 | 0.050 |
Why?
|
| PPAR gamma | 2 | 2012 | 66 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2004 | 669 | 0.050 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 30 | 0.050 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2020 | 4 | 0.050 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 32 | 0.050 |
Why?
|
| Cerebellar Vermis | 1 | 2020 | 5 | 0.050 |
Why?
|
| Polymicrogyria | 1 | 2020 | 10 | 0.050 |
Why?
|
| Basilar Artery | 1 | 2020 | 41 | 0.050 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2020 | 39 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2006 | 1208 | 0.050 |
Why?
|
| Smad Proteins | 2 | 2010 | 39 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 3362 | 0.040 |
Why?
|
| Illinois | 1 | 2021 | 462 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 76 | 0.040 |
Why?
|
| Glycosaminoglycans | 1 | 2019 | 47 | 0.040 |
Why?
|
| Chondroitin Sulfates | 1 | 2019 | 43 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2019 | 86 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2019 | 62 | 0.040 |
Why?
|
| Chitosan | 1 | 2019 | 18 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2019 | 164 | 0.040 |
Why?
|
| Cross Infection | 1 | 2020 | 141 | 0.040 |
Why?
|
| Transgenes | 1 | 2019 | 180 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2020 | 127 | 0.040 |
Why?
|
| Transposon Resolvases | 1 | 2018 | 7 | 0.040 |
Why?
|
| Osteotomy, Le Fort | 1 | 2018 | 5 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2018 | 25 | 0.040 |
Why?
|
| Calcium Phosphates | 1 | 2019 | 77 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 1801 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 493 | 0.040 |
Why?
|
| Intraoperative Care | 1 | 2018 | 82 | 0.040 |
Why?
|
| Bone Plates | 2 | 2007 | 23 | 0.040 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2017 | 7 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 2426 | 0.040 |
Why?
|
| Silicates | 1 | 2017 | 8 | 0.040 |
Why?
|
| Graphite | 1 | 2017 | 12 | 0.040 |
Why?
|
| Critical Care | 1 | 2020 | 370 | 0.040 |
Why?
|
| Transformation, Genetic | 1 | 2017 | 40 | 0.040 |
Why?
|
| Simian virus 40 | 1 | 2017 | 35 | 0.040 |
Why?
|
| Apoptosis | 1 | 2004 | 1683 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 154 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2018 | 185 | 0.040 |
Why?
|
| Curriculum | 1 | 2021 | 539 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2017 | 143 | 0.040 |
Why?
|
| Antioxidants | 1 | 2018 | 223 | 0.040 |
Why?
|
| North America | 1 | 2017 | 180 | 0.040 |
Why?
|
| Tectum Mesencephali | 1 | 2016 | 4 | 0.040 |
Why?
|
| Acrylic Resins | 1 | 2016 | 22 | 0.040 |
Why?
|
| Citrates | 1 | 2016 | 28 | 0.040 |
Why?
|
| Mandibular Advancement | 1 | 2016 | 6 | 0.030 |
Why?
|
| Oropharynx | 1 | 2016 | 15 | 0.030 |
Why?
|
| Materials Testing | 1 | 2016 | 91 | 0.030 |
Why?
|
| Internal Fixators | 1 | 2016 | 14 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2003 | 2261 | 0.030 |
Why?
|
| Cartilage | 1 | 2016 | 113 | 0.030 |
Why?
|
| Prognosis | 1 | 2004 | 3679 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2016 | 31 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2016 | 141 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2017 | 254 | 0.030 |
Why?
|
| Respiratory System | 1 | 2016 | 116 | 0.030 |
Why?
|
| Virus Replication | 1 | 2017 | 319 | 0.030 |
Why?
|
| Melanoma, Experimental | 1 | 2016 | 103 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2017 | 300 | 0.030 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2015 | 10 | 0.030 |
Why?
|
| Meningitis | 1 | 2015 | 20 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2017 | 679 | 0.030 |
Why?
|
| Osteomyelitis | 1 | 2015 | 54 | 0.030 |
Why?
|
| Wnt3A Protein | 1 | 2014 | 23 | 0.030 |
Why?
|
| Forecasting | 1 | 2016 | 304 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 996 | 0.030 |
Why?
|
| Rotation | 1 | 2014 | 89 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 969 | 0.030 |
Why?
|
| Veins | 1 | 2013 | 94 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2015 | 328 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 572 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2767 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2013 | 96 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 130 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 379 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2013 | 2501 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 174 | 0.030 |
Why?
|
| Integrases | 1 | 2012 | 59 | 0.030 |
Why?
|
| Graft Survival | 1 | 2015 | 884 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 1078 | 0.020 |
Why?
|
| Petrous Bone | 1 | 2011 | 11 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2010 | 4 | 0.020 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2011 | 25 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2010 | 21 | 0.020 |
Why?
|
| Temporomandibular Joint | 1 | 2011 | 20 | 0.020 |
Why?
|
| Cranial Fossa, Middle | 1 | 2011 | 11 | 0.020 |
Why?
|
| Implants, Experimental | 1 | 2010 | 16 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2010 | 62 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 253 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2010 | 60 | 0.020 |
Why?
|
| Base Sequence | 1 | 2014 | 2330 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2010 | 22 | 0.020 |
Why?
|
| Alveolar Bone Loss | 1 | 2010 | 20 | 0.020 |
Why?
|
| Risk Factors | 2 | 2013 | 5417 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2010 | 92 | 0.020 |
Why?
|
| Goldenhar Syndrome | 1 | 2009 | 2 | 0.020 |
Why?
|
| Speech Intelligibility | 1 | 2009 | 10 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 262 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 1036 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2010 | 153 | 0.020 |
Why?
|
| Fetus | 1 | 2010 | 226 | 0.020 |
Why?
|
| Ribs | 1 | 2009 | 45 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 853 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 322 | 0.020 |
Why?
|
| Maternal Age | 1 | 2008 | 44 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2008 | 104 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 236 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 370 | 0.020 |
Why?
|
| Jaw Fixation Techniques | 1 | 2007 | 3 | 0.020 |
Why?
|
| Titanium | 1 | 2007 | 20 | 0.020 |
Why?
|
| Health Surveys | 1 | 2008 | 239 | 0.020 |
Why?
|
| Esthetics | 1 | 2007 | 44 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 1313 | 0.020 |
Why?
|
| Rejuvenation | 1 | 2006 | 18 | 0.020 |
Why?
|
| Malocclusion | 1 | 2006 | 6 | 0.020 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2006 | 15 | 0.020 |
Why?
|
| Body Image | 1 | 2006 | 76 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 689 | 0.020 |
Why?
|
| Arthroplasty | 1 | 2006 | 27 | 0.020 |
Why?
|
| Oxidants | 1 | 2006 | 86 | 0.020 |
Why?
|
| Self Concept | 1 | 2006 | 133 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 2006 | 80 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2006 | 319 | 0.020 |
Why?
|
| Sex Factors | 1 | 2008 | 1054 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 1014 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2006 | 447 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2008 | 1621 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 1135 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 1384 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1749 | 0.010 |
Why?
|